Open AccessThe Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis
Author(s) -
Emily P. Hyle,
Ilesh Jani,
Jonathan Lehe,
Amanda Su,
Robin Wood,
Jorge I. Quevedo,
Elena Losina,
Ingrid V. Bassett,
Pamela P. Pei,
A. David Paltiel,
Stephen Resch,
Kenneth A. Freedberg,
Trevor Peter,
Rochelle P. Walensky
Publication year - 2014
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1001725
Subject(s) - per capita , life expectancy , medicine , gross domestic product , point of care testing , point of care , demography , cost effectiveness , health care , linkage (software) , cohort , cohort study , population , environmental health , immunology , economic growth , economics , nursing , risk analysis (engineering) , sociology , biochemistry , chemistry , gene
Emily Hyle and colleagues conduct a cost-effectiveness analysis to estimate the clinical and economic impact of point-of-care CD4 testing compared to laboratory-based tests in Mozambique. Please see later in the article for the Editors' Summary
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom